MEP23008A - Aminoalkylbenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same - Google Patents
Aminoalkylbenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing sameInfo
- Publication number
- MEP23008A MEP23008A MEP-230/08A MEP23008A MEP23008A ME P23008 A MEP23008 A ME P23008A ME P23008 A MEP23008 A ME P23008A ME P23008 A MEP23008 A ME P23008A
- Authority
- ME
- Montenegro
- Prior art keywords
- same
- benzofuran
- aminoalkylbenzoyl
- compositions containing
- benzothiophene derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D307/84—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D307/80—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Heart & Thoracic Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Furan Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0010834A FR2813306B1 (fr) | 2000-08-23 | 2000-08-23 | Aminoalkybenzoyl-benzofurannes ou benzothiophenes, leur procede de preparation et les compositions les contenant |
| PCT/FR2001/002640 WO2002016339A1 (fr) | 2000-08-23 | 2001-08-21 | Aminoalkylbenzoyl-benzofuranes ou benzothiophenes, leur procede de preparation et les compositions les contenant |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MEP23008A true MEP23008A (en) | 2010-06-10 |
Family
ID=8853674
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MEP-230/08A MEP23008A (en) | 2000-08-23 | 2001-08-21 | Aminoalkylbenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same |
| MEP-2008-230A ME00106B (me) | 2000-08-23 | 2001-08-21 | Derivati aminoalkenilbenzoil-benzofurana ili benzotiopena, postupak za njihovo pripremanje i kompozicije koje ih sadrže |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MEP-2008-230A ME00106B (me) | 2000-08-23 | 2001-08-21 | Derivati aminoalkenilbenzoil-benzofurana ili benzotiopena, postupak za njihovo pripremanje i kompozicije koje ih sadrže |
Country Status (36)
| Country | Link |
|---|---|
| US (1) | US6949583B2 (ru) |
| EP (1) | EP1315709B1 (ru) |
| JP (2) | JP5081363B2 (ru) |
| KR (1) | KR100911280B1 (ru) |
| CN (1) | CN1246315C (ru) |
| AR (1) | AR032892A1 (ru) |
| AT (1) | ATE469138T1 (ru) |
| AU (2) | AU8414901A (ru) |
| BG (1) | BG66240B1 (ru) |
| BR (1) | BR0113425B1 (ru) |
| CA (1) | CA2415847C (ru) |
| CY (1) | CY1110738T1 (ru) |
| CZ (1) | CZ304003B6 (ru) |
| DE (1) | DE60142240D1 (ru) |
| DK (1) | DK1315709T3 (ru) |
| EA (1) | EA006237B1 (ru) |
| ES (1) | ES2346291T3 (ru) |
| FR (1) | FR2813306B1 (ru) |
| HK (1) | HK1053113A1 (ru) |
| HU (1) | HU229456B1 (ru) |
| IL (2) | IL153632A0 (ru) |
| IS (1) | IS2821B (ru) |
| MA (1) | MA26943A1 (ru) |
| ME (2) | MEP23008A (ru) |
| MX (1) | MXPA03001463A (ru) |
| NO (1) | NO328138B1 (ru) |
| NZ (1) | NZ523446A (ru) |
| OA (1) | OA12359A (ru) |
| PL (1) | PL219848B1 (ru) |
| PT (1) | PT1315709E (ru) |
| RS (1) | RS51603B (ru) |
| SI (1) | SI1315709T1 (ru) |
| SK (1) | SK288126B6 (ru) |
| TW (1) | TWI290920B (ru) |
| WO (1) | WO2002016339A1 (ru) |
| ZA (1) | ZA200300744B (ru) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7401072B2 (en) * | 2003-06-10 | 2008-07-15 | Google Inc. | Named URL entry |
| WO2007086911A2 (en) * | 2005-05-05 | 2007-08-02 | Sanofi-Aventis U.S. Llc | Stable nanoparticle formulations |
| FR2893616B1 (fr) * | 2005-11-23 | 2008-01-04 | Sanofi Aventis Sa | Nouveaux derives d'indolizine, leur procede de preparation et les compositions therapeutiques les comprenant |
| CN1946120B (zh) * | 2006-10-20 | 2010-05-12 | 华为技术有限公司 | 实现话单关联的方法及系统 |
| EP2308488A1 (en) | 2009-10-09 | 2011-04-13 | Sanofi-Aventis | Use of celivarone for the preparation of a medicament for use in the prevention of implantable cardioverter defibrillator interventions or death |
| US20110207811A1 (en) * | 2010-02-19 | 2011-08-25 | Sanofi-Aventis | Use of celivarone for reducing occurrences of cardiovascular hospitalization |
| FR2958290B1 (fr) | 2010-03-30 | 2012-10-19 | Sanofi Aventis | Procede de preparation de derives de sulfonamido-benzofurane |
| HUP1000330A2 (en) | 2010-06-18 | 2011-12-28 | Sanofi Sa | Process for the preparation of dronedarone and the novel intermediates |
| AU2011202542A1 (en) | 2010-07-14 | 2012-02-02 | Indian Institute Of Science | Benzothiophene carboxamide compounds, composition and applications thereof |
| FR2963006B1 (fr) | 2010-07-21 | 2013-03-15 | Sanofi Aventis | Procede de preparation de derives de nitro-benzofurane |
| FR2967067A1 (fr) | 2010-11-10 | 2012-05-11 | Sanofi Aventis | Composition pharmaceutique et forme galenique a base de dronedarone et son procede de preparation |
| HUP1100167A2 (en) | 2011-03-29 | 2012-11-28 | Sanofi Sa | Process for preparation of dronedarone by mesylation |
| HUP1100165A2 (en) | 2011-03-29 | 2012-12-28 | Sanofi Sa | Process for preparation of dronedarone by n-butylation |
| CN102757444B (zh) * | 2011-04-29 | 2016-02-10 | 南京信诺泰医药有限公司 | 具有一氧化氮供体性质的苯并呋喃类化合物 |
| FR2983198B1 (fr) | 2011-11-29 | 2013-11-15 | Sanofi Sa | Procede de preparation de derives de 5-amino-benzoyl-benzofurane |
| EP2617718A1 (en) | 2012-01-20 | 2013-07-24 | Sanofi | Process for preparation of dronedarone by the use of dibutylaminopropanol reagent |
| WO2013121235A2 (en) | 2012-02-13 | 2013-08-22 | Sanofi | Process for preparation of dronedarone by removal of hydroxyl group |
| WO2013121234A1 (en) | 2012-02-14 | 2013-08-22 | Sanofi | Process for the preparation of dronedarone by oxidation of a sulphenyl group |
| WO2013124745A1 (en) | 2012-02-22 | 2013-08-29 | Sanofi | Process for preparation of dronedarone by oxidation of a hydroxyl group |
| WO2013178337A1 (en) | 2012-05-31 | 2013-12-05 | Sanofi | Process for preparation of dronedarone by grignard reaction |
| CN105315245B (zh) * | 2014-06-16 | 2018-10-12 | 华润赛科药业有限责任公司 | 苯并呋喃类衍生物、其制备方法和应用 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3248401A (en) * | 1966-04-26 | Diethylaminoe hoxybenzoyl benzofurans | ||
| GB1345872A (en) * | 1970-09-03 | 1974-02-06 | Wyeth John & Brother Ltd | Amino-and acylamino-pyridine and hydropyridine derivatives |
| US4851554A (en) | 1987-04-06 | 1989-07-25 | University Of Tennessee Research Corporation | Certain 3-substituted 2-alkyl benzofuran derivatives |
| US4806663A (en) | 1987-04-06 | 1989-02-21 | The University Of Tennessee Research Corporation | Certain 3-substituted 2-alkyl benzofuran derivatives |
| US4831054A (en) * | 1988-04-18 | 1989-05-16 | Taro Pharmaceuticals, Ltd. | 2-Alkyl-3-benzoylbenzofurans useful for treating cardiac arrhythmia |
| AT391316B (de) | 1988-09-15 | 1990-09-25 | Ebewe Arzneimittel | Neue thienyloxy-alkylamin-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
| FR2665444B1 (fr) * | 1990-08-06 | 1992-11-27 | Sanofi Sa | Derives d'amino-benzofuranne, benzothiophene ou indole, leur procede de preparation ainsi que les compositions les contenant. |
| JP3157882B2 (ja) * | 1991-11-15 | 2001-04-16 | 帝国臓器製薬株式会社 | 新規なベンゾチオフエン誘導体 |
| US5482949A (en) | 1993-03-19 | 1996-01-09 | Eli Lilly And Company | Sulfonate derivatives of 3-aroylbenzo[b]thiophenes |
| US5364880A (en) * | 1993-06-16 | 1994-11-15 | Advanced Therapies, Inc. | Compound for treatment of cardiac arrhythmia, synthesis, and methods of use |
| US6756388B1 (en) * | 1993-10-12 | 2004-06-29 | Pfizer Inc. | Benzothiophenes and related compounds as estrogen agonists |
| US5482950A (en) * | 1993-10-15 | 1996-01-09 | Eli Lilly And Company | Methods for lowering serum cholesterol |
| US5523309A (en) * | 1995-03-10 | 1996-06-04 | Eli Lilly And Company | Benzofuran pharmaceutical compounds |
| CA2217373A1 (en) * | 1996-10-10 | 1998-04-10 | Michael John Martin | Benzo¬b|thiophene compounds, intermediates, formulations, and methods |
-
2000
- 2000-08-23 FR FR0010834A patent/FR2813306B1/fr not_active Expired - Fee Related
-
2001
- 2001-08-21 IL IL15363201A patent/IL153632A0/xx active IP Right Grant
- 2001-08-21 AU AU8414901A patent/AU8414901A/xx active Pending
- 2001-08-21 SI SI200130974T patent/SI1315709T1/sl unknown
- 2001-08-21 ES ES01963113T patent/ES2346291T3/es not_active Expired - Lifetime
- 2001-08-21 BR BRPI0113425-6A patent/BR0113425B1/pt not_active IP Right Cessation
- 2001-08-21 RS YU12903A patent/RS51603B/sr unknown
- 2001-08-21 HU HU0302968A patent/HU229456B1/hu not_active IP Right Cessation
- 2001-08-21 KR KR1020037002618A patent/KR100911280B1/ko active IP Right Grant
- 2001-08-21 EA EA200300062A patent/EA006237B1/ru not_active IP Right Cessation
- 2001-08-21 CA CA2415847A patent/CA2415847C/fr not_active Expired - Fee Related
- 2001-08-21 OA OA1200300035A patent/OA12359A/fr unknown
- 2001-08-21 DE DE60142240T patent/DE60142240D1/de not_active Expired - Lifetime
- 2001-08-21 CN CNB018177670A patent/CN1246315C/zh not_active Expired - Fee Related
- 2001-08-21 JP JP2002521440A patent/JP5081363B2/ja not_active Expired - Fee Related
- 2001-08-21 PL PL362119A patent/PL219848B1/pl unknown
- 2001-08-21 EP EP01963113A patent/EP1315709B1/fr not_active Expired - Lifetime
- 2001-08-21 NZ NZ523446A patent/NZ523446A/xx not_active IP Right Cessation
- 2001-08-21 US US10/362,324 patent/US6949583B2/en not_active Expired - Lifetime
- 2001-08-21 PT PT01963113T patent/PT1315709E/pt unknown
- 2001-08-21 AU AU2001284149A patent/AU2001284149B2/en not_active Ceased
- 2001-08-21 MX MXPA03001463A patent/MXPA03001463A/es active IP Right Grant
- 2001-08-21 WO PCT/FR2001/002640 patent/WO2002016339A1/fr active IP Right Grant
- 2001-08-21 DK DK01963113.4T patent/DK1315709T3/da active
- 2001-08-21 SK SK216-2003A patent/SK288126B6/sk not_active IP Right Cessation
- 2001-08-21 AT AT01963113T patent/ATE469138T1/de active
- 2001-08-21 ME MEP-230/08A patent/MEP23008A/xx unknown
- 2001-08-21 CZ CZ20030521A patent/CZ304003B6/cs not_active IP Right Cessation
- 2001-08-21 ME MEP-2008-230A patent/ME00106B/me unknown
- 2001-08-22 TW TW090120633A patent/TWI290920B/zh not_active IP Right Cessation
- 2001-08-23 AR ARP010104023A patent/AR032892A1/es not_active Application Discontinuation
-
2002
- 2002-12-24 IL IL153632A patent/IL153632A/en not_active IP Right Cessation
-
2003
- 2003-01-13 IS IS6677A patent/IS2821B/is unknown
- 2003-01-28 ZA ZA200300744A patent/ZA200300744B/xx unknown
- 2003-02-05 BG BG107527A patent/BG66240B1/bg unknown
- 2003-02-17 MA MA27042A patent/MA26943A1/fr unknown
- 2003-02-20 NO NO20030800A patent/NO328138B1/no not_active IP Right Cessation
- 2003-07-25 HK HK03105391.1A patent/HK1053113A1/xx not_active IP Right Cessation
-
2010
- 2010-08-17 CY CY20101100763T patent/CY1110738T1/el unknown
-
2011
- 2011-12-14 JP JP2011273790A patent/JP5603849B2/ja not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MEP23008A (en) | Aminoalkylbenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same | |
| CY1105387T1 (el) | Υποκατεστημενα παραγωγα 2-διαλκυλαμινοαλκυλοδιφαινθλιου | |
| IS6658A (is) | Ný efnasambönd | |
| DE60003949D1 (de) | 5-aryl-1h-1,2,4 triazolverbindungen als cyclooxygenase -2 inhibitoren und dieseenthaltende pharmazeutische zusammensetzungen | |
| EE05091B1 (et) | Oligosahhariidid, nende valmistamismeetod ja kasutamine ning farmatseutilised kompositsioonid | |
| NO20043016L (no) | 6-aminomorfinan-derivater, fremgangsmate for fremstilling og anvendelse derav | |
| IL153959A0 (en) | Aminoalkoxybenzoyl-banzofuran or benzothiophene derivatives, method for preparing same and compositions containing same | |
| SE9804212D0 (sv) | Compounds | |
| WO2005011609A3 (en) | Triazolopurine-based tricyclic compounds and pharmaceutical compositions comprising same | |
| YU37597A (en) | New pyranosid derivatives | |
| SE9904128D0 (sv) | Novel compounds | |
| ZA200300746B (en) | Aminoalkenylbenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same. | |
| ATE336493T1 (de) | Tricyclische epoxide | |
| WO2002083641A3 (en) | Amino-aza-cyclohexanes for the treatment of malaria |